- Home
- RVMD vs RGA Comparison
RVMD vs RGA Comparison
Compare RVMD & RGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | RGA |
|---|---|---|
| Founded | 2014 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 14.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RVMD | RGA |
|---|---|---|
| Price | $103.19 | $213.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 10 |
| Target Price | $114.63 | ★ $240.00 |
| AVG Volume (30 Days) | ★ 1.7M | 438.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $552.08 | $5.81 |
| P/E Ratio | ★ N/A | $12.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.17 | $159.25 |
| 52 Week High | $124.49 | $229.21 |
Technical Indicators
Market Signals| Indicator | RVMD | RGA |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 49.96 |
| Support Level | $92.76 | $193.54 |
| Resistance Level | $124.49 | $229.21 |
| Average True Range (ATR) | 3.62 | 5.64 |
| MACD | 0.23 | -0.89 |
| Stochastic Oscillator | 67.28 | 1.19 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About RGA Reinsurance Group of America Incorporated
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.